Back
Monte Rosa Therapeutics Vs. Avis Budget Group Industry Stock Comparison
Buy
60
GLUE
Monte Rosa Therapeutics
Last Price:
$6.29
Seasonality Move:
-16.98%
Sell
29
CAR
Avis Budget Group
Last Price:
$61.97
Seasonality Move:
41.93%
Buy
60
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
-
The current Monte Rosa Therapeutics [GLUE] share price is $6.21. The Score for GLUE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GLUE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Avis Budget Group (CAR)
is a Sell
Is Avis Budget Group a Buy, Sell or Hold?
-
The current Avis Budget Group [CAR] share price is $55.49. The Score for CAR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
CAR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $6.21The current trend is relatively stagnant and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
CAR Stock Price Chart
What is Avis Budget Group's stock price today?
-
The Avis Budget Group share price today is $55.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAR is experiencing selling pressure, which indicates risk of future bearish movement.
GLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 50.13 | Buy |
Chaikin Money Flow: | -285490 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.86 - 6.72) | Sell |
Bollinger Bands (100): | (5.67 - 8.63) | Sell |
CAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.76 | Sell |
Relative Strength Index (14 RSI): | 20.15 | Sell |
Chaikin Money Flow: | -2411607 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.74 - 92.2) | Sell |
Bollinger Bands (100): | (78.79 - 98.77) | Sell |
GLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.14 | Buy |
20-day SMA: | 6.18 | Buy |
50-day SMA: | 6.26 | Sell |
200-day SMA: | 5.95 | Buy |
8-day EMA: | 6.21 | Buy |
20-day EMA: | 6.19 | Buy |
50-day EMA: | 6.42 | Sell |
200-day EMA: | 6.33 | Sell |
CAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 69.7 | Sell |
20-day SMA: | 80.19 | Sell |
50-day SMA: | 84.43 | Sell |
200-day SMA: | 91.92 | Sell |
8-day EMA: | 68.26 | Sell |
20-day EMA: | 76.58 | Sell |
50-day EMA: | 83.19 | Sell |
200-day EMA: | 97.06 | Sell |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.
Avis Budget Group Earnings Growth & CAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.65 per share, a decrease next quarter of $13.89 per share, an increase this year of $4.19 per share, and an increase next year of $5.44 per share.
Monte Rosa Therapeutics Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avis Budget Group Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |